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Abstract: Voxel-based morphometry (VBM) has detected differences between brains of groups of patients
with epilepsy and controls, but the sensitivity for detecting subtle pathological changes in single subjects
has not been established. The aim of the study was to test the sensitivity of VBM using statistical paramet-
ric mapping (SPM5) to detect hippocampal sclerosis (HS) and cortical neuronal loss in individual patients.
T1-weighted volumetric 1.5 T MR images from 13 patients with HS and laminar cortical neuronal loss
were segmented, normalised and smoothed using SPM5. Both modulated and non-modulated analyses
were performed. Comparisons of one control subject against the rest (n ¼ 23) were ﬁrst performed to ascer-
tain the smoothing level with the lowest number of SPM changes in controls. Each patient was then com-
pared against the whole control group. The lowest number of SPM changes in control subjects was found
at a smoothing level of 10 mm full width half maximum for modulated and non-modulated data. In the
patient group, no SPM abnormalities were found in the affected temporal lobe or hippocampus at this
smoothing level. At lower smoothing levels there were numerous SPM ﬁndings in controls and patients.
VBM did not detect any abnormalities associated with either laminar cortical neuronal loss or HS. This
may be due to normalisation and smoothing of images and low statistical power in areas with larger inter-
individual differences. This suggests that the methodology may currently not be suitable to detect particu-
lar occult abnormalities possibly associated with seizure onset zone in individual epilepsy patients with
unremarkable standard structural MRI. Hum Brain Mapp 30:3351–3360, 2009. V C 2009 Wiley-Liss, Inc.
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INTRODUCTION
Voxel-based morphometry (VBM) is a whole-brain semi-
automated technique for characterising structural brain
differences in vivo [Ashburner and Friston, 2000]. VBM
and statistical parametric mapping (SPM) of segmented
grey matter images have been useful in identifying subtle
group differences in brain structure in a variety of diseases
associated with neurological and psychiatric dysfunction
and the technique has frequently been used to study
patients with epilepsy [Bernasconi et al., 2004; Betting
et al., 2006; Bonilha et al., 2006; Colliot et al., 2006; Keller
et al., 2002, 2004; Mueller et al., 2006; Woermann et al.,
1999a,b]. However, the underlying pathological bases of
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sitivity for detecting subtle pathological changes, particu-
larly in single subjects, is unclear.
Hippocampal sclerosis (HS) is the most common cause
of refractory temporal lobe epilepsy. Histopathologically,
HS is characterised by neuronal loss and gliosis. The neu-
ron loss in classical HS is greatest in CA1 and the hilar
region (including CA4) with accompanying gliosis [Bruton,
1988]. HS can readily be identiﬁed on MRI. The cardinal
signs of HS on MRI are increased hippocampal signal on
T2-weighted images and hippocampal volume loss most
evident on T1-weighted images [Jackson et al., 1990]. Pre-
vious VBM group analyses of patients with HS have
detected reduced grey matter in the ipsilateral hippocam-
pus as well as more widespread changes often involving
both hemispheres [Bernasconi et al., 2004; Cormack et al.,
2005; Keller et al., 2002, 2004]. HS has, however, not been
detected in individual patients using a previous version of
SPM [Woermann et al., 1999a].
Hippocampal sclerosis may be associated with temporal
lobe neocortical changes such as lack of neurones in layers
II–III associated with gliosis [Thom et al., 2000] (see Fig.
1). It has recently been suggested that these changes might
represent a type of subtle developmental anomaly (focal
cortical dysplasia type Ia) [Garbelli et al., 2006]. It is also
possible that the changes could be a result of frequent
seizures with secondary neuronal loss and appearance of
clusters of adjacent cells in layer II; a similar pattern of
neuronal loss has been seen in an animal model of status
epilepticus [Roch et al., 2002]. Such subtle changes are not
identiﬁed in humans on visual inspection of routine MRI,
but may be obvious on histopathological sections.
In the preoperative work-up of individuals for epilepsy
surgery, it is important to detect cerebral abnormalities
that might be associated with epilepsy and may be a
marker for the seizure onset zone. It is also recognised
that up to one third of patients with isolated hippocampal
sclerosis do not become seizure free following temporal
lobectomy. It is not known why some of these rigorously
screened and carefully selected patients continue to have
seizures and it is pivotal to improve the diagnosis of
cytoarchitectural abnormalities that might inﬂuence post-
operative outcome. To increase the sensitivity of the pre-
operative investigations, it is necessary to improve MRI
Figure 1.
Histopathological section through the temporal lobe approxi-
mately 1.5 cm from the tip of the temporal pole stained with
NeuN (Patient 2) (a). The cortex displays neuronal loss in
layer III and an appearance of clusters of neurons in layer II
which is seen more clearly in higher magniﬁcation of the cor-
tex in the same patient (b). Normal cortex for comparison (c).
Laminar gliosis, corresponding to the cortical areas with neuro-
nal loss, is seen on the GFAP immunostained section in the
same case (Patient 2) (d). This is seen more clearly in the
higher magniﬁcation of the cortex in the same patient (e). This
also shows the subpial (Chaslin’s) gliosis more clearly. [Color
ﬁgure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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rent study was to test the sensitivity of VBM, using SPM5,
by studying individual patients with known HS (that is
readily seen on routine MRI) and cortical neuronal loss
(not seen on routine MRI) compared with a group of con-
trols, to evaluate the ability of the method to identify
subtle abnormalities in vivo, and so contribute to pre-
surgical evaluation.
MATERIALS AND METHODS
The study was approved by the Joint Research Ethics
Committee of the National Hospital for Neurology and
Neurosurgery and Institute of Neurology, UCL. All partic-
ipants gave written informed consent. We studied 13 epi-
lepsy surgery patients undergoing anterior temporal lobe
resections (ATLR) at the National Hospital for Neurology
and Neurosurgery, who had preoperative T1-weighted
volume scans at the National Society for Epilepsy and in
whom postoperative histopathological evaluation revealed
HS and cortical neuronal loss in layer II-III of the neocor-
tex. Qualitative histopathology showed varying degrees of
neuronal depletion from the deeper part of cortical layer II
extending to the upper part of layer III. Remaining neuro-
nes in layer II appeared aggregated in clusters or groups,
with in some cases an apparent hypercellularity and abnor-
mal orientation of residual layer II neurones. There were
no dysmorphic or hypertrophic neurones and no balloon
cells. The laminar neuronal depletion was accompanied by
an excessive cellular gliosis extending from cortical layer I
to III as visualised with GFAP staining (see Fig. 1).
In addition to HS, one of the patients also had a degree
of ipsilateral temporal lobe atrophy seen on MRI (Patient
2). In all other patients, MRI showed HS but no other
abnormalities. Hippocampal volumes and T2 values were
measured in all but two patients (Patients 7 and 11, Table
III) [Duncan et al., 1996; Woermann et al., 1998]. Volume
ratios between the sclerotic side and the unaffected side
ranged between 38% and 76% (abnormal ratio deﬁned as
<90%). T2 values on the sclerotic side ranged between
90.1 and 99 ms (abnormal value deﬁned as >90 ms). T2
values on the unaffected side in the 11 cases where mea-
surements were made were normal in 10 cases but
increased to 91 ms in 1 case (Patient 8) (for details see
Table III).
The age range of the patients was 24–55 years (median,
36 years) and four were female. Six had a right ATLR, and
seven had surgery on the left. Outcome was assessed
according to the ILAE criteria [ILAE, 2001] at the latest fol-
low-up, median 5 years after surgery (range, 2–8 years).
For further clinical details, please see Table I. Surgery was
performed after our standard presurgical work-up, includ-
ing EEG-video telemetry, conventional MRI (T1- and T2-
weighted, proton density and FLAIR), psychological and
psychiatric assessments and multi-disciplinary case confer-
ence. The control group constituted of 24 healthy control
subjects with no history of any neurological disorders. The
age range was 20–51 years (median, 35 years) and there
were 15 females.
MR Acquisition
All scans were acquired on the same 1.5T GE Signa MR
scanner (GE Medical Systems, Milwaukee, WI) using the
standard circularly polarised quadrature birdcage coil. The
parameters for T1-weighted volume sequence were: TE/
TR/TI/NEX, 4.2/15/450/1; ﬂip angle 20 degrees;
TABLE I. Clinical data
a
Patient
Gender/side
of surgery
Age at
onset/duration
(years) Precipitating insult Seizure frequency
Outcome
of surgery
1 M/left 1.5/32.5 CFS at 17 months 1 CPS/month 1
2 F/right 11/25 Meningitis at 7 months 7 CPS/month 1
3 M/right 11/36 Repeated FS 3–4 SPS/day, 2 CPS/month 1
4 M/right 13/23 CFS at 18 months 20 SPS/month, 5 CPS/month 1
5 M/right 9/20 Traumatic brain injury, brief LOC at 8 years 4 CPS/month, 1 SGTCS/month 3
6 M/left 1.5/35 FS at 8 months, CFS at 18 months 10–15 CPS/month 1
7 M/right 11/16 Meningitis at 6 months 8 CPS/month, 2–4 SGTCS/year 2
8 M/right 5/32 CFS at 9 months, FS at 13 and 14 months 4–6 CPS/month 1
9 F/left 22/11 FS 10 CPS/month 1
10 M/left 2/36 Encephalitis at 18 months 3 CPS/month 4
11 M/left 0.75/23 2 FS at 9 months 5–6 CPS/month 1
12 M/left 13/42 2 FS at 9 months 3–6 CPS/month 1
13 F/left 6/33 CFS at 9 months 4 CPS/month 1
aNumbers indicate outcome group according to the ILAE criteria [ILAE, 2001]. 1, no seizures; 2, auras only; 3, seizures on less than
4 days a year; 4, seizures reduced by more than 50%. Outcome > 2 years after surgery.
M, male; F, female; CFS, complex febrile seizure; FS, febrile seizure; LOC, loss of consciousness; CPS, complex partial seizure; SPS, sim-
ple partial seizure; SGTCS, secondary generalised tonic clonic seizure.
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r 3353 racquisition matrix 256   192; ﬁeld of view 24   18 cm; 3/
4 phase FOV, 124 contiguous 1.5 mm slices, giving a voxel
size of 0.94   1.25   1.5 mm. All patients also had T2-
weighted and proton density (TE1/TE2/TR 30/80/2000
FOV 24   18 cm, acquisition matrix 256   192, slice thick-
ness 5.0 mm, giving a voxel size of 0.94   0.94   5.0 mm)
and FLAIR images (TE/TR/TI 144/11000/2250, FOV 24  
24 cm, acquisition matrix 256   224, slice thickness 5.0
mm, giving a voxel size of 0.94   1.1   5.0 mm). Scans
were acquired coronally.
VBM Procedures
The T1-weighted volume scans were reformatted to
axial orientation and into cubic voxels (0.94 mm
3) before
SPM analyses.
Modulated Images
For the comparisons of ‘‘modulated’’ images, the refor-
matted images were then segmented and normalised using
the uniﬁed segmentation of SPM5 (FIL, Wellcome Trust
Centre for Neuroimaging, London, UK). The grey matter
segmentations were modulated with the Jacobian ﬁelds to
preserve the individual grey matter amount (‘‘preserve
amount’’ option in SPM5). Voxel size option was set to 1
  1   1 (instead of the default 2   2   2) mm to retain
maximum image information.
The segmented grey matter class images were smoothed
using an isotropic Gaussian kernel to improve signal to
noise ratio, to allow the images to conform more closely to
a Gaussian ﬁeld model and to increase the validity of sta-
tistical inference. Smoothing levels from 4 to 10 mm full-
width half-maximum (FWHM) were used. A standard uni-
variate t-test was applied using SPM5 to every voxel in
the image in order to create a map from which statistical
inference was drawn. Signiﬁcant increases or decreases in
MR contrast signal intensity were detected at an individ-
ual voxel threshold of P < 0.001. The theory of Gaussian
ﬁelds was used to calculate a corrected multiple compari-
son P value of 0.05. The cluster extent threshold was set to
ﬁve voxels. Each control was ﬁrst compared against the
rest of the control group to ascertain the smoothing level
with adequate speciﬁcity (i.e. few changes detected in con-
trol subjects). At a statistical threshold of P < 0.05 and 48
examinations (24 control subjects with two contrasts each,
increase and decrease) up to 2.4 abnormalities may be
expected by chance across the group. The smoothing levels
were then applied to the patients and we tested for
regional differences between each patient and the control
group.
Uncorrected Comparisons: Modulated Images
To further assess the sensitivity of the procedures,
uncorrected comparisons between each patient and the
control group were performed on the modulated data
smoothed using 10 mm FWHM.
Non-Modulated Images
We also applied what has been described by Wilke et al.
[2003] as the most sensitive approach to identify focal cort-
ical dysplasia (FCD); afﬁne registration, non-linear warp-
ing using discrete cosine transform with a non-linear cut
off of 25 mm, 16 non-linear iterations and default (me-
dium) regularisation, ‘‘non-modulated’’ images. Following
this, the procedures were the same as for the modulated
images. Smoothing levels of 6 and 10 mm FWHM were
used.
No group analyses were performed since the localisa-
tion, extent and severity of the neocortical changes varied
and the aim of the study was to investigate sensitivity for
individual patients.
RESULTS
Modulated Images: Control Subjects
At a smoothing level of 10 mm FWHM, SPM5 detected
an area of increased grey matter in one of 24 controls. At
Figure 2.
Example of abnormalities detected by SPM5 in a control subject.
Sagittal, coronal (top row) and axial (bottom row) views of seg-
mented grey matter images (smoothing level 6 mm FWHM) for
control subject 19. Areas with increases in grey matter detected
by SPM5 in the right fronto-polar and fronto-parietal regions are
superimposed. [Color ﬁgure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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matter in eight subjects (33%) at smoothing of 8 mm
FWHM, 16 subjects (66%) at smoothing of 6 mm FWHM
and four subjects (17%) at a smoothing level of 4 mm
FWHM (Figs. 2 and 3). Details are listed in Table II. There
were no decreases in grey matter for control subjects at
any smoothing level used. Since we would expect an area
of reduced grey matter associated with the histopathologi-
cal changes seen in our patients, all smoothing levels were
also applied to the patients.
Modulated Imaged: Patients
At a smoothing level of 10 mm FWHM, the smoothing
level with highest speciﬁcity identiﬁed by comparing one
control against the rest, there were no SPM5 abnormalities
in any of the patients. With reduced smoothing levels,
SPM5 detected increases in grey matter in three patients
(23%) at smoothing of 8 mm FWHM, seven patients (53%) at
smoothing of 6 mm FWHM and two patients (15%) at
smoothing of 4 mm FWHM. One of the areas with grey mat-
ter increase seen at a smoothing of 6 mm FWHM was in the
temporal lobe that was resected but posterior to the resec-
tion (Patient 3). None of the other abnormalities were in
areas related to the seizure focus (deﬁned as the temporal
lobe and hippocampus resected during surgery). There was
only one patient with an SPM5-detected area of decrease in
grey matter and this appeared in the cerebellum at smooth-
ing levels of 4 and 6 mm FWHM (Patient 2). There were no
SPM abnormalities in the hippocampus in any patient at
any smoothing level. Details are given in Table III.
Uncorrected Comparisons: Modulated Images
The uncorrected comparisons using a smoothing level of
10 mm FWHM detected scattered increases in grey matter
in 6 of the 13 patients (46%). None of the changes were in
the hippocampus or affected temporal lobe. There were no
decreases.
Non-Modulated: Control Subjects
At a smoothing level of 6 mm FWHM, SPM5 detected
increases in grey matter in seven (29%) and decreases in
ﬁve (21%) of 24 control subjects. At a smoothing level of
10 mm FWHM there were ﬁve control subjects (21%) with
increases in grey matter and a decrease was seen in two
control subject (8%). Since a smoothing level of 6 mm
FWHM gave several (i.e. >2.4 that could have been
expected by chance) decreases in control subjects, only a
smoothing of 10 mm FWHM was applied to patients.
Non-Modulated: Patients
At a smoothing of 10 mm FWHM there were two
patients with increases and two patients (15%) with
decreases in grey matter compared to the control group.
In one patient (Patient 3) the increase was in the affected
temporal lobe, but was more extensive than the abnormal-
ity seen using the modulated images and extended to the
posterior part of the temporal lobe resection. However,
there were frequent increases in control subjects at these
settings and the signiﬁcance of the increase seen is ques-
tionable. None of the other abnormalities detected were in
the affected temporal lobe or hippocampus, the decreases
were left fronto-polar (Patient 3) and in the cerebellum
(Patient 2). Details are given in Table III.
DISCUSSION
VBM has been used in several studies of patients with
temporal lobe epilepsy. Most studies have found group dif-
ferences in grey matter between patients and control sub-
jects [Bernasconi et al., 2004; Cormack et al., 2005; Keller
et al., 2002, 2004; Mueller et al., 2006]. Analyses of individ-
ual patients, however, are needed for such analyses to be
clinically useful. In the current study, we investigated indi-
vidual patients with HS and a known subtle neocortical
abnormality. However, no SPM abnormalities were found
in the affected temporal lobe or hippocampus in individual
patients using analyses with sufﬁcient speciﬁcity.
The sensitivity of VBM of T1-weighted volume scans in
detecting cerebral abnormalities associated with epilepsy
in individual patients has not been established. Previous
studies of individual patients with focal cortical dysplasia
(FCD) using voxel-based analyses, have demonstrated that
every visually identiﬁed lesion, or the full extent of these
lesions, are often not detected using VBM even though
abnormalities remote from the visually identiﬁed lesions
are commonly shown [Bonilha et al., 2006; Colliot et al.,
2006]. Not ﬁnding every FCD lesion or the full extent of
lesions might partly be due to MRI signal increases associ-
ated with FCD, but might also be due to normalisation
issues. Normalisation of data is necessary for comparisons
between individuals. Normalising data can, however,
reduce differences between individual patients by making
Figure 3.
Graph showing the number of SPM5 detected abnormalities in
patients and control subjects for each smoothing levels used,
modulated images.
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ity to abnormalities.
In our ﬁrst comparative analyses we used a standard
VBM procedure, modulated normalisation, that is thought
to compensate, for example, for disproportionate stretch-
ing of parts of images [Good et al., 2001]. Modulation is
usually needed to account for the global and local effect of
the spatial normalisation. However, since this was not sen-
sitive in detecting abnormalities in individual patients we
also applied non-modulated afﬁne normalisation proce-
dures that have been suggested to be more sensitive to
detecting FCD [Wilke et al., 2003]. Wilke et al. could show
that with a more liberal normalisation method, modulation
is crucial, however with a more restricted normalisation
algorithm like in the proposed ‘‘ideal method’’ modulation
may be less important. An advantage of not using modu-
lation is the better homogeneity of the data since global
changes like total grey matter volume (bigger brains) are
modelled out. Both methods, however, produced numer-
ous changes in control subjects at lower smoothing levels,
a matter not addressed by Wilke and colleagues [Wilke
et al., 2003], but no deﬁnite abnormalities in patients when
smoothing levels were increased to reduce the number of
changes in control subjects. Additionally the sensitivity
was not greater with the non-modulated than the modu-
lated analysis.
It has previously been shown that changing thresholds
for voxel-based comparisons to increase speciﬁcity will
reduce sensitivity in individual patients with FCD [Colliot
et al., 2006]. Smoothing of data also inﬂuences the results of
VBM analyses. Whilst smoothing is needed to allow the
images to conform more closely to a Gaussian ﬁeld model
and to increase the validity of statistical inference [Friston
et al., 1995], excessive smoothing might reduce the chance of
detecting any subtle abnormalities if the smoothing kernel is
greater in extent than the expected pathology. It has, how-
ever, been shown that greater levels of smoothing (>8m m
FWHM) may be needed to ensure comparisons are valid
when comparing single subjects to a group [Salmond et al.,
2002]. Our normalisation and smoothing procedures were
optimised for speciﬁcity in the control group, i.e., to reduce
the number of abnormalities seen in the control group. The
cortical changes identiﬁed histopathologically ranged from
one to several gyri in one to six tissue blocks (equivalent to
between  5 mm and approximately 30 mm). The most
subtle changes were therefore smaller than all smoothing
levels used, but the more extensive were greater than these.
In contrast to a previous study [Salmond et al., 2002],
we found that the analyses were more sensitive to
increases in grey matter than to decreases, i.e. there were
numerous increases in grey matter volume in control sub-
jects as well as patients, but fewer decreases in grey mat-
ter. The cortical neuronal loss in the patients would be
expected to cause a reduction in grey matter volume, but
no temporal lobe decreases were detected using any of the
modulated or non-modulated methods or smoothing lev-
els. Further, VBM did not detect the HS (that results in a
reduction in grey matter volume) in any of the patients.
Previous VBM studies detecting grey matter changes in
temporal lobe epilepsy and HS have been group studies
[Bernasconi et al., 2004; Cormack et al., 2005; Keller et al.,
2002, 2004; Mueller et al., 2006]. Our current results are in
agreement with a previous study of individual patients
with HS from our group using SPM96 [Woermann et al.,
1999a]. No group analyses were performed in the current
study since the extent and severity of changes were heter-
ogeneous and the purpose of the work was to assess the
sensitivity of VBM in individual patients.
There has been debate regarding whether VBM analyses
have sufﬁcient statistical power to detect structural abnor-
malities in individual brains [Ashburner and Friston, 2000].
Further, there have been discussions about reduced VBM
sensitivity if images are not correctly registered [Ashburner
and Friston, 2001; Bookstein, 2001] and suggestions that
VBM results in, for example, dementia should be corrobo-
rated by volumetric studies [Allen et al., 2005]. VBM analy-
ses are based on statistical signiﬁcance thresholding, where
thresholds are estimated using random ﬁeld theory to cor-
rect for multiple dependent comparisons [Worsley et al.,
1996]. These thresholds offer strong control over type I
errors (false positives) at the expense of statistical power or
control over false negatives. This is most apparent in
regions with variable distribution of grey matter where
even large lesions may not be detected using VBM [Mehta
et al., 2003]. This might partly explain the failure of SPM/
VBM to detect HS in individuals since the anatomy of the
medial temporal structures can vary greatly even between
normal control subjects. There were also a larger proportion
of females in the control group. It is possible that a larger
control group might increase the sensitivity, but decommis-
sioning of our 1.5T scanner curtailed any further scanning
at this ﬁeld strength comparable to patient data. We have,
however, detected changes in individual epilepsy patients
previously using VBM and several different MRI sequences
using a similar number of control subjects [Eriksson et al.,
2001; Rugg-Gunn et al., 2003, 2005, 2006; Salmenpera et al.,
2007].
In FCD, changes have been detected in individual
patients [Bonilha et al., 2006; Colliot et al., 2006]. In these
cases there is often an increase in grey matter, which is
correspondingly thickened on histopathological analysis. It
is possible that such changes are more easily detected
using VBM than reductions in grey matter in areas that
might also have great inter-individual variability. No anal-
yses of cortical thickness were possible on the histopatho-
logical sections since it could not be ascertained that
sections were cut perpendicular to the cortex, and
obliquely cut sections could have falsely given the impres-
sion of increased thickness.
In summary, using VBM and SPM5 of T1-weighted vol-
ume images we could not detect HS or cortical neuronal
loss in individual epilepsy patients. This suggests that the
methodology might currently not be suitable to detect cer-
tain types of occult abnormalities possibly associated with
r Eriksson et al. r
r 3358 rseizure onset zone in individual patients in whom visual
inspection of routine MRI shows no abnormalities.
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